Delivery Order SPE2DE24DA017-SPE2D626F72U8
- Not listed
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $6,600.00 for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions was awarded on September 23, 2025, with an ultimate completion date of September 26, 2025. The contract was issued without a set-aside designation, reflecting Arthrex's strong competitive position in the federal medical...
- Arthrex Inc., headquartered in Naples, Florida, has been awarded a delivery order valued at $1,650 for the Arthrex ACP Double Syringe System, with an ultimate completion date of January 14, 2026. The award was issued on December 30, 2025, under a fixed-price contract with economic price adjustment terms. There is no set-aside designation associated with this procurement. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, a defense agency supporting orthopedic...
- Arthrex Inc., a leading global orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a $8,664.00 fixed-price delivery order for the ARTHREX ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025. The delivery order, which carries an ultimate completion date of July 28, 2025, represents a task order against Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) valued at $471,048,172.66 and running through...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $4,950 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 18, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of September 23, 2025, was awarded without a set-aside designation, reflecting Arthrex's strong competitive standing in the federal orthopedic medical device marketplace. The...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475 on August 6, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 11, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain. The contract carries no...
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical devices based in Naples, Florida, was awarded a delivery order valued at $2,475.00 for the Arthrex ACP Double Syringe System, with an ultimate completion date of December 5, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation and will be performed in Naples, Florida. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which procures...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $2,475 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment capability was awarded on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract represents no set-aside designation,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, received a $4,950 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the Arthrex ACP Double Syringe System. The contract, classified as a non-set-aside delivery order with an ultimate completion date of August 22, 2025, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $10,393.29 for the Arthrex ACP Double Syringe System on December 10, 2025, with an ultimate completion date of December 15, 2025. This fixed-price delivery order with economic price adjustment falls under a larger single-award Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at $471 million...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F72U8Delivery Order
Arthrex Inc., a leading manufacturer of minimally invasive orthopedic surgical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $6,380.22 for the Arthrex ACP Double Syringe System on January 2, 2026, with an ultimate completion date of January 7, 2026. This fixed-price contract with economic price adjustment was issued without set-aside designation by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for supplying medical equipment to Department of Defense and Department of Veterans Affairs healthcare systems. The place of performance is located in Naples, Florida, where Arthrex maintains its primary operations. This delivery order was issued under Arthrex's existing single-award Indefinite Delivery Contract SPE2DE24D0020 with the Defense Logistics Agency's Medical Supply Chain, a comprehensive $471 billion contract vehicle effective from June 2024 through September 2029 that authorizes procurement of Arthrex's full portfolio of orthopedic products and surgical technologies. Arthrex serves as the prime contractor with no identified subcontractors, reflecting the company's established direct relationships with federal agencies and its demonstrated capacity to fulfill government orthopedic healthcare requirements independently. The ACP Double Syringe System represents one of numerous delivery orders being executed under this master contract to support orthopedic surgical procedures across Department of Defense and Veterans Affairs medical facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 1/1/26 |